CompletedNCT01133821
Interpersonal and social rhythm therapy with quetiapine or placebo for depression in bipolarity
Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 92
- Sponsor
- Holly Swartz
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01133821
- Official title
Show the full official title
Acute Psychotherapy for Bipolar II Depression
Get this study by email
Recruitment & locations
CompletedPittsburgh
Questions about this study
Who is behind this study?
The study sponsor is Holly Swartz.
Did this study involve medication?
Yes. The study involved medication, including IPSRT plus placebo (IPSRT-PLA) and IPSRT plus quetiapine.
Who was this study for?
Listed age limits: 18 years to 65 years.
